Aralez Pharmaceuticals Inc. (fka ARLZQ)

[georgie18]

ARLZQ...004...Nice move to .0115 followed by a dip to the .002 range which left an open gap in the .006 range that should fill...

Chart...http://schrts.co/eQegvnDT

https://www.otcmarkets.com/filing/html?id=13162447&guid=dBktUn0Vr9ul-th

Effective as of January 18, 2019, Sanjay Subramanian, 43, the Company’s current Treasurer, will assume the role of Chief Financial Officer. Prior to joining the company, Mr. Subramanian was the Director of Treasury at Bausch Health Companies. Mr. Subramanian started his finance career at General Motors Co. where he held various positions before leaving as the Treasurer of GM Korea.

Effective as of January 31, 2019, Christopher Freeland, 40, the Company’s current General Counsel, will also assume the role of Chief Operating Officer. Prior to being appointed as the Company’s General Counsel, Mr. Freeland was the Company’s Associate General Counsel. Prior to joining the Company, Mr. Freeland was an Associate General Counsel at American International Group. Mr. Freeland started his legal career as a corporate associate at Willkie Farr & Gallagher LLP.